36 /100
MEDIUM RISK
Score updated Jun 14, 2026

AXSM — Axsome Therapeutics, Inc. Dilution Risk Tracker

Track AXSM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AXSM — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for AXSM.
🔔 Track AXSM — Get forecast alerts →

💹 Market Data

Market Cap$12.07B
Shares Outstanding51.46M
Float43.55M
Cash$305.11M
Debt$187.85M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 10.9% shares (2026Q1 vs prior)
418 institutional holders · 44.34M shares
#1 BlackRock, Inc. 3.91M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 3.88M shares
#3 VANGUARD PORTFOLIO MANAGEMENT LLC 2.06M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.78M
Days to Cover2.9
% of Float6.4%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2016
4 INSIDER TRANSACTION Apr 23, 2026
4 INSIDER TRANSACTION Apr 23, 2026
4 INSIDER TRANSACTION Apr 23, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track AXSM Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AXSM — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

🔬 More Research for AXSM
📊 AXSM FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 AXSM Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.